Global Heparin Sodium Injection Supply, Demand and Key Producers, 2026-2032
The global Heparin Sodium Injection market size is expected to reach $ 4679 million by 2032, rising at a market growth of 6.1% CAGR during the forecast period (2026-2032).
Heparin Sodium Injection is a natural anticoagulant drug derived from animal tissues, typically porcine intestinal mucosa or bovine lung, which functions by activating antithrombin III to inhibit thrombin (Factor IIa) and Factor Xa in the blood coagulation cascade, thereby preventing and treating thrombus formation. This drug is widely used in cardiovascular surgeries, hemodialysis, prevention of venous thromboembolism, and treatment of acute or chronic thrombotic disorders such as pulmonary embolism. Heparin was first extracted and applied clinically in the 1930s, and over decades of development, mature injection formulations have been established. The production of Heparin Sodium Injection relies on the supply of high-purity animal-derived raw materials and requires rigorous extraction, purification, and sterilization processes, while upstream components including injection-grade water, buffer solutions, sterilization equipment, and packaging materials are provided by specialized suppliers to ensure product safety and stability.In 2025, the global production capacity of heparin sodium injection was 210 million boxes, with sales volume reaching 189 million boxes, an average unit price of 15.9 USD per box, and corporate gross profit margins ranging between 25% and 35%.
Heparin Sodium Injection currently maintains a solid presence in both global and China markets, entrenched as a fundamental anticoagulant within clinical practice. Although newer low molecular weight heparins and direct oral anticoagulants have gradually expanded therapeutic choices, heparin sodium remains indispensable in acute settings, surgical procedures, extracorporeal circulation, and critical care due to its rapid onset, reversible action, and cost-effectiveness. Its long-standing inclusion in clinical pathways and familiarity among healthcare professionals contribute to stable demand, while conservative treatment patterns in many healthcare systems reinforce its continued use, particularly in teaching hospitals and primary care facilities. This has formed a mature ecosystem around the supply and clinical utilization of the product.
Looking forward, the evolution of heparin sodium is expected to be multi-faceted. The shift toward precision medicine and individualized care is driving more refined clinical use, paired with improved monitoring tools to enhance safety and efficacy. At the same time, advancements in manufacturing and quality control are fostering higher purity production technologies that can reduce immunogenic side effects and broaden its utility in specific patient populations. Regulatory tightening globally prompts manufacturers to strengthen quality compliance throughout the supply chain, presenting an opportunity for domestic producers to enhance international competitiveness. Meanwhile, the progression of heparin derivatives, innovative anticoagulant peptides, and alternative mechanisms is subtly reshaping the landscape of anticoagulant therapy, prompting re-evaluation of heparin sodium?s positioning and combination strategies with new agents.
The continued momentum for heparin sodium stems from several core drivers. The unceasing clinical need for reliable anticoagulation, especially in high-risk and complex cases, underscores its enduring relevance; its manufacturing scalability and cost advantage support broad accessibility across diverse healthcare settings; and policy initiatives that emphasize stable supply of essential medicines provide institutional reinforcement for its market. Nevertheless, challenges persist. Competing anticoagulants with improved patient adherence and convenience are encroaching on traditional indications; product safety concerns and supply chain vulnerabilities, such as raw material quality and pathogen control, can affect confidence; and an increasingly stringent regulatory environment alongside shifting investment toward innovative therapies may impact industry dynamics and resource allocation. To navigate this evolving landscape, heparin sodium?s role in future practice will rely on balancing its established clinical value with advancements in technology and quality standards.
This report studies the global Heparin Sodium Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Heparin Sodium Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Heparin Sodium Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Heparin Sodium Injection total production and demand, 2021-2032, (K Units)
Global Heparin Sodium Injection total production value, 2021-2032, (USD Million)
Global Heparin Sodium Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Heparin Sodium Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Heparin Sodium Injection domestic production, consumption, key domestic manufacturers and share
Global Heparin Sodium Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Heparin Sodium Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Heparin Sodium Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Heparin Sodium Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva Pharmaceutical Industries, Fresenius Kabi, Qilu Pharmaceutical, Cisen Pharmaceutical, Fosun Pharma, Changshan Biochemical Pharmaceutical, China Resources Double-Crane, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Heparin Sodium Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Heparin Sodium Injection Market, By Region:
1. How big is the global Heparin Sodium Injection market?
2. What is the demand of the global Heparin Sodium Injection market?
3. What is the year over year growth of the global Heparin Sodium Injection market?
4. What is the production and production value of the global Heparin Sodium Injection market?
5. Who are the key producers in the global Heparin Sodium Injection market?
6. What are the growth factors driving the market demand?
Heparin Sodium Injection is a natural anticoagulant drug derived from animal tissues, typically porcine intestinal mucosa or bovine lung, which functions by activating antithrombin III to inhibit thrombin (Factor IIa) and Factor Xa in the blood coagulation cascade, thereby preventing and treating thrombus formation. This drug is widely used in cardiovascular surgeries, hemodialysis, prevention of venous thromboembolism, and treatment of acute or chronic thrombotic disorders such as pulmonary embolism. Heparin was first extracted and applied clinically in the 1930s, and over decades of development, mature injection formulations have been established. The production of Heparin Sodium Injection relies on the supply of high-purity animal-derived raw materials and requires rigorous extraction, purification, and sterilization processes, while upstream components including injection-grade water, buffer solutions, sterilization equipment, and packaging materials are provided by specialized suppliers to ensure product safety and stability.In 2025, the global production capacity of heparin sodium injection was 210 million boxes, with sales volume reaching 189 million boxes, an average unit price of 15.9 USD per box, and corporate gross profit margins ranging between 25% and 35%.
Heparin Sodium Injection currently maintains a solid presence in both global and China markets, entrenched as a fundamental anticoagulant within clinical practice. Although newer low molecular weight heparins and direct oral anticoagulants have gradually expanded therapeutic choices, heparin sodium remains indispensable in acute settings, surgical procedures, extracorporeal circulation, and critical care due to its rapid onset, reversible action, and cost-effectiveness. Its long-standing inclusion in clinical pathways and familiarity among healthcare professionals contribute to stable demand, while conservative treatment patterns in many healthcare systems reinforce its continued use, particularly in teaching hospitals and primary care facilities. This has formed a mature ecosystem around the supply and clinical utilization of the product.
Looking forward, the evolution of heparin sodium is expected to be multi-faceted. The shift toward precision medicine and individualized care is driving more refined clinical use, paired with improved monitoring tools to enhance safety and efficacy. At the same time, advancements in manufacturing and quality control are fostering higher purity production technologies that can reduce immunogenic side effects and broaden its utility in specific patient populations. Regulatory tightening globally prompts manufacturers to strengthen quality compliance throughout the supply chain, presenting an opportunity for domestic producers to enhance international competitiveness. Meanwhile, the progression of heparin derivatives, innovative anticoagulant peptides, and alternative mechanisms is subtly reshaping the landscape of anticoagulant therapy, prompting re-evaluation of heparin sodium?s positioning and combination strategies with new agents.
The continued momentum for heparin sodium stems from several core drivers. The unceasing clinical need for reliable anticoagulation, especially in high-risk and complex cases, underscores its enduring relevance; its manufacturing scalability and cost advantage support broad accessibility across diverse healthcare settings; and policy initiatives that emphasize stable supply of essential medicines provide institutional reinforcement for its market. Nevertheless, challenges persist. Competing anticoagulants with improved patient adherence and convenience are encroaching on traditional indications; product safety concerns and supply chain vulnerabilities, such as raw material quality and pathogen control, can affect confidence; and an increasingly stringent regulatory environment alongside shifting investment toward innovative therapies may impact industry dynamics and resource allocation. To navigate this evolving landscape, heparin sodium?s role in future practice will rely on balancing its established clinical value with advancements in technology and quality standards.
This report studies the global Heparin Sodium Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Heparin Sodium Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Heparin Sodium Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Heparin Sodium Injection total production and demand, 2021-2032, (K Units)
Global Heparin Sodium Injection total production value, 2021-2032, (USD Million)
Global Heparin Sodium Injection production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Heparin Sodium Injection consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Heparin Sodium Injection domestic production, consumption, key domestic manufacturers and share
Global Heparin Sodium Injection production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Heparin Sodium Injection production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Heparin Sodium Injection production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Heparin Sodium Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva Pharmaceutical Industries, Fresenius Kabi, Qilu Pharmaceutical, Cisen Pharmaceutical, Fosun Pharma, Changshan Biochemical Pharmaceutical, China Resources Double-Crane, Shenzhen Hepalink Pharmaceutical, Nanjing King-friend Biochemical Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Heparin Sodium Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Heparin Sodium Injection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 1, 000 USP Units / mL
- 5, 000 USP Units / mL
- 10, 000 USP Units / mL
- Unfractionated Heparin (UFH)
- Low Molecular Weight Heparin (LMWH)
- Intravenous Injection (IV)
- Subcutaneous Injection (SC)
- Treatment of Venous Thromboembolism
- Complications of Pregnancy
- Cardioversion of Atrial Fibrillation/Flutter
- Other
- Pfizer
- Teva Pharmaceutical Industries
- Fresenius Kabi
- Qilu Pharmaceutical
- Cisen Pharmaceutical
- Fosun Pharma
- Changshan Biochemical Pharmaceutical
- China Resources Double-Crane
- Shenzhen Hepalink Pharmaceutical
- Nanjing King-friend Biochemical Pharmaceutical
- Chengdu Qianhong Bio-pharma
- Dongying Tiandong Pharmaceutical
- Jiangxi Haoran Bio-pharmaceutical
- North China Pharmaceutical Group Huakun
- Chengdu Haitong Pharmaceutical
1. How big is the global Heparin Sodium Injection market?
2. What is the demand of the global Heparin Sodium Injection market?
3. What is the year over year growth of the global Heparin Sodium Injection market?
4. What is the production and production value of the global Heparin Sodium Injection market?
5. Who are the key producers in the global Heparin Sodium Injection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Heparin Sodium Injection Introduction
1.2 World Heparin Sodium Injection Supply & Forecast
1.2.1 World Heparin Sodium Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Heparin Sodium Injection Production (2021-2032)
1.2.3 World Heparin Sodium Injection Pricing Trends (2021-2032)
1.3 World Heparin Sodium Injection Production by Region (Based on Production Site)
1.3.1 World Heparin Sodium Injection Production Value by Region (2021-2032)
1.3.2 World Heparin Sodium Injection Production by Region (2021-2032)
1.3.3 World Heparin Sodium Injection Average Price by Region (2021-2032)
1.3.4 North America Heparin Sodium Injection Production (2021-2032)
1.3.5 Europe Heparin Sodium Injection Production (2021-2032)
1.3.6 China Heparin Sodium Injection Production (2021-2032)
1.3.7 Japan Heparin Sodium Injection Production (2021-2032)
1.3.8 India Heparin Sodium Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Heparin Sodium Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Heparin Sodium Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Heparin Sodium Injection Demand (2021-2032)
2.2 World Heparin Sodium Injection Consumption by Region
2.2.1 World Heparin Sodium Injection Consumption by Region (2021-2026)
2.2.2 World Heparin Sodium Injection Consumption Forecast by Region (2027-2032)
2.3 United States Heparin Sodium Injection Consumption (2021-2032)
2.4 China Heparin Sodium Injection Consumption (2021-2032)
2.5 Europe Heparin Sodium Injection Consumption (2021-2032)
2.6 Japan Heparin Sodium Injection Consumption (2021-2032)
2.7 South Korea Heparin Sodium Injection Consumption (2021-2032)
2.8 ASEAN Heparin Sodium Injection Consumption (2021-2032)
2.9 India Heparin Sodium Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Heparin Sodium Injection Production Value by Manufacturer (2021-2026)
3.2 World Heparin Sodium Injection Production by Manufacturer (2021-2026)
3.3 World Heparin Sodium Injection Average Price by Manufacturer (2021-2026)
3.4 Heparin Sodium Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Heparin Sodium Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Heparin Sodium Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Heparin Sodium Injection in 2025
3.6 Heparin Sodium Injection Market: Overall Company Footprint Analysis
3.6.1 Heparin Sodium Injection Market: Region Footprint
3.6.2 Heparin Sodium Injection Market: Company Product Type Footprint
3.6.3 Heparin Sodium Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Heparin Sodium Injection Production Value Comparison
4.1.1 United States VS China: Heparin Sodium Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Heparin Sodium Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Heparin Sodium Injection Production Comparison
4.2.1 United States VS China: Heparin Sodium Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Heparin Sodium Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Heparin Sodium Injection Consumption Comparison
4.3.1 United States VS China: Heparin Sodium Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Heparin Sodium Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Heparin Sodium Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Heparin Sodium Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Heparin Sodium Injection Production (2021-2026)
4.5 China Based Heparin Sodium Injection Manufacturers and Market Share
4.5.1 China Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Heparin Sodium Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Heparin Sodium Injection Production (2021-2026)
4.6 Rest of World Based Heparin Sodium Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Heparin Sodium Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Heparin Sodium Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Heparin Sodium Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 1, 000 USP Units / mL
5.2.2 5, 000 USP Units / mL
5.2.3 10, 000 USP Units / mL
5.3 Market Segment by Type
5.3.1 World Heparin Sodium Injection Production by Type (2021-2032)
5.3.2 World Heparin Sodium Injection Production Value by Type (2021-2032)
5.3.3 World Heparin Sodium Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MOLECULAR WEIGHT
6.1 World Heparin Sodium Injection Market Size Overview by Molecular Weight: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Molecular Weight
6.2.1 Unfractionated Heparin (UFH)
6.2.2 Low Molecular Weight Heparin (LMWH)
6.3 Market Segment by Molecular Weight
6.3.1 World Heparin Sodium Injection Production by Molecular Weight (2021-2032)
6.3.2 World Heparin Sodium Injection Production Value by Molecular Weight (2021-2032)
6.3.3 World Heparin Sodium Injection Average Price by Molecular Weight (2021-2032)
7 MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
7.1 World Heparin Sodium Injection Market Size Overview by Route of Administration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Route of Administration
7.2.1 Intravenous Injection (IV)
7.2.2 Subcutaneous Injection (SC)
7.3 Market Segment by Route of Administration
7.3.1 World Heparin Sodium Injection Production by Route of Administration (2021-2032)
7.3.2 World Heparin Sodium Injection Production Value by Route of Administration (2021-2032)
7.3.3 World Heparin Sodium Injection Average Price by Route of Administration (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Heparin Sodium Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Treatment of Venous Thromboembolism
8.2.2 Complications of Pregnancy
8.2.3 Cardioversion of Atrial Fibrillation/Flutter
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Heparin Sodium Injection Production by Application (2021-2032)
8.3.2 World Heparin Sodium Injection Production Value by Application (2021-2032)
8.3.3 World Heparin Sodium Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer Heparin Sodium Injection Product and Services
9.1.4 Pfizer Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Teva Pharmaceutical Industries
9.2.1 Teva Pharmaceutical Industries Details
9.2.2 Teva Pharmaceutical Industries Major Business
9.2.3 Teva Pharmaceutical Industries Heparin Sodium Injection Product and Services
9.2.4 Teva Pharmaceutical Industries Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.2.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.3 Fresenius Kabi
9.3.1 Fresenius Kabi Details
9.3.2 Fresenius Kabi Major Business
9.3.3 Fresenius Kabi Heparin Sodium Injection Product and Services
9.3.4 Fresenius Kabi Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Fresenius Kabi Recent Developments/Updates
9.3.6 Fresenius Kabi Competitive Strengths & Weaknesses
9.4 Qilu Pharmaceutical
9.4.1 Qilu Pharmaceutical Details
9.4.2 Qilu Pharmaceutical Major Business
9.4.3 Qilu Pharmaceutical Heparin Sodium Injection Product and Services
9.4.4 Qilu Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Qilu Pharmaceutical Recent Developments/Updates
9.4.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
9.5 Cisen Pharmaceutical
9.5.1 Cisen Pharmaceutical Details
9.5.2 Cisen Pharmaceutical Major Business
9.5.3 Cisen Pharmaceutical Heparin Sodium Injection Product and Services
9.5.4 Cisen Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Cisen Pharmaceutical Recent Developments/Updates
9.5.6 Cisen Pharmaceutical Competitive Strengths & Weaknesses
9.6 Fosun Pharma
9.6.1 Fosun Pharma Details
9.6.2 Fosun Pharma Major Business
9.6.3 Fosun Pharma Heparin Sodium Injection Product and Services
9.6.4 Fosun Pharma Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Fosun Pharma Recent Developments/Updates
9.6.6 Fosun Pharma Competitive Strengths & Weaknesses
9.7 Changshan Biochemical Pharmaceutical
9.7.1 Changshan Biochemical Pharmaceutical Details
9.7.2 Changshan Biochemical Pharmaceutical Major Business
9.7.3 Changshan Biochemical Pharmaceutical Heparin Sodium Injection Product and Services
9.7.4 Changshan Biochemical Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Changshan Biochemical Pharmaceutical Recent Developments/Updates
9.7.6 Changshan Biochemical Pharmaceutical Competitive Strengths & Weaknesses
9.8 China Resources Double-Crane
9.8.1 China Resources Double-Crane Details
9.8.2 China Resources Double-Crane Major Business
9.8.3 China Resources Double-Crane Heparin Sodium Injection Product and Services
9.8.4 China Resources Double-Crane Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 China Resources Double-Crane Recent Developments/Updates
9.8.6 China Resources Double-Crane Competitive Strengths & Weaknesses
9.9 Shenzhen Hepalink Pharmaceutical
9.9.1 Shenzhen Hepalink Pharmaceutical Details
9.9.2 Shenzhen Hepalink Pharmaceutical Major Business
9.9.3 Shenzhen Hepalink Pharmaceutical Heparin Sodium Injection Product and Services
9.9.4 Shenzhen Hepalink Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
9.9.6 Shenzhen Hepalink Pharmaceutical Competitive Strengths & Weaknesses
9.10 Nanjing King-friend Biochemical Pharmaceutical
9.10.1 Nanjing King-friend Biochemical Pharmaceutical Details
9.10.2 Nanjing King-friend Biochemical Pharmaceutical Major Business
9.10.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium Injection Product and Services
9.10.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
9.10.6 Nanjing King-friend Biochemical Pharmaceutical Competitive Strengths & Weaknesses
9.11 Chengdu Qianhong Bio-pharma
9.11.1 Chengdu Qianhong Bio-pharma Details
9.11.2 Chengdu Qianhong Bio-pharma Major Business
9.11.3 Chengdu Qianhong Bio-pharma Heparin Sodium Injection Product and Services
9.11.4 Chengdu Qianhong Bio-pharma Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Chengdu Qianhong Bio-pharma Recent Developments/Updates
9.11.6 Chengdu Qianhong Bio-pharma Competitive Strengths & Weaknesses
9.12 Dongying Tiandong Pharmaceutical
9.12.1 Dongying Tiandong Pharmaceutical Details
9.12.2 Dongying Tiandong Pharmaceutical Major Business
9.12.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product and Services
9.12.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
9.12.6 Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
9.13 Jiangxi Haoran Bio-pharmaceutical
9.13.1 Jiangxi Haoran Bio-pharmaceutical Details
9.13.2 Jiangxi Haoran Bio-pharmaceutical Major Business
9.13.3 Jiangxi Haoran Bio-pharmaceutical Heparin Sodium Injection Product and Services
9.13.4 Jiangxi Haoran Bio-pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Jiangxi Haoran Bio-pharmaceutical Recent Developments/Updates
9.13.6 Jiangxi Haoran Bio-pharmaceutical Competitive Strengths & Weaknesses
9.14 North China Pharmaceutical Group Huakun
9.14.1 North China Pharmaceutical Group Huakun Details
9.14.2 North China Pharmaceutical Group Huakun Major Business
9.14.3 North China Pharmaceutical Group Huakun Heparin Sodium Injection Product and Services
9.14.4 North China Pharmaceutical Group Huakun Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 North China Pharmaceutical Group Huakun Recent Developments/Updates
9.14.6 North China Pharmaceutical Group Huakun Competitive Strengths & Weaknesses
9.15 Chengdu Haitong Pharmaceutical
9.15.1 Chengdu Haitong Pharmaceutical Details
9.15.2 Chengdu Haitong Pharmaceutical Major Business
9.15.3 Chengdu Haitong Pharmaceutical Heparin Sodium Injection Product and Services
9.15.4 Chengdu Haitong Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Chengdu Haitong Pharmaceutical Recent Developments/Updates
9.15.6 Chengdu Haitong Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Heparin Sodium Injection Industry Chain
10.2 Heparin Sodium Injection Upstream Analysis
10.2.1 Heparin Sodium Injection Core Raw Materials
10.2.2 Main Manufacturers of Heparin Sodium Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Heparin Sodium Injection Production Mode
10.6 Heparin Sodium Injection Procurement Model
10.7 Heparin Sodium Injection Industry Sales Model and Sales Channels
10.7.1 Heparin Sodium Injection Sales Model
10.7.2 Heparin Sodium Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Heparin Sodium Injection Introduction
1.2 World Heparin Sodium Injection Supply & Forecast
1.2.1 World Heparin Sodium Injection Production Value (2021 & 2025 & 2032)
1.2.2 World Heparin Sodium Injection Production (2021-2032)
1.2.3 World Heparin Sodium Injection Pricing Trends (2021-2032)
1.3 World Heparin Sodium Injection Production by Region (Based on Production Site)
1.3.1 World Heparin Sodium Injection Production Value by Region (2021-2032)
1.3.2 World Heparin Sodium Injection Production by Region (2021-2032)
1.3.3 World Heparin Sodium Injection Average Price by Region (2021-2032)
1.3.4 North America Heparin Sodium Injection Production (2021-2032)
1.3.5 Europe Heparin Sodium Injection Production (2021-2032)
1.3.6 China Heparin Sodium Injection Production (2021-2032)
1.3.7 Japan Heparin Sodium Injection Production (2021-2032)
1.3.8 India Heparin Sodium Injection Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Heparin Sodium Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Heparin Sodium Injection Major Market Trends
2 DEMAND SUMMARY
2.1 World Heparin Sodium Injection Demand (2021-2032)
2.2 World Heparin Sodium Injection Consumption by Region
2.2.1 World Heparin Sodium Injection Consumption by Region (2021-2026)
2.2.2 World Heparin Sodium Injection Consumption Forecast by Region (2027-2032)
2.3 United States Heparin Sodium Injection Consumption (2021-2032)
2.4 China Heparin Sodium Injection Consumption (2021-2032)
2.5 Europe Heparin Sodium Injection Consumption (2021-2032)
2.6 Japan Heparin Sodium Injection Consumption (2021-2032)
2.7 South Korea Heparin Sodium Injection Consumption (2021-2032)
2.8 ASEAN Heparin Sodium Injection Consumption (2021-2032)
2.9 India Heparin Sodium Injection Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Heparin Sodium Injection Production Value by Manufacturer (2021-2026)
3.2 World Heparin Sodium Injection Production by Manufacturer (2021-2026)
3.3 World Heparin Sodium Injection Average Price by Manufacturer (2021-2026)
3.4 Heparin Sodium Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Heparin Sodium Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Heparin Sodium Injection in 2025
3.5.3 Global Concentration Ratios (CR8) for Heparin Sodium Injection in 2025
3.6 Heparin Sodium Injection Market: Overall Company Footprint Analysis
3.6.1 Heparin Sodium Injection Market: Region Footprint
3.6.2 Heparin Sodium Injection Market: Company Product Type Footprint
3.6.3 Heparin Sodium Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Heparin Sodium Injection Production Value Comparison
4.1.1 United States VS China: Heparin Sodium Injection Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Heparin Sodium Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Heparin Sodium Injection Production Comparison
4.2.1 United States VS China: Heparin Sodium Injection Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Heparin Sodium Injection Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Heparin Sodium Injection Consumption Comparison
4.3.1 United States VS China: Heparin Sodium Injection Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Heparin Sodium Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Heparin Sodium Injection Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Heparin Sodium Injection Production Value (2021-2026)
4.4.3 United States Based Manufacturers Heparin Sodium Injection Production (2021-2026)
4.5 China Based Heparin Sodium Injection Manufacturers and Market Share
4.5.1 China Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Heparin Sodium Injection Production Value (2021-2026)
4.5.3 China Based Manufacturers Heparin Sodium Injection Production (2021-2026)
4.6 Rest of World Based Heparin Sodium Injection Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Heparin Sodium Injection Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Heparin Sodium Injection Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Heparin Sodium Injection Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 1, 000 USP Units / mL
5.2.2 5, 000 USP Units / mL
5.2.3 10, 000 USP Units / mL
5.3 Market Segment by Type
5.3.1 World Heparin Sodium Injection Production by Type (2021-2032)
5.3.2 World Heparin Sodium Injection Production Value by Type (2021-2032)
5.3.3 World Heparin Sodium Injection Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MOLECULAR WEIGHT
6.1 World Heparin Sodium Injection Market Size Overview by Molecular Weight: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Molecular Weight
6.2.1 Unfractionated Heparin (UFH)
6.2.2 Low Molecular Weight Heparin (LMWH)
6.3 Market Segment by Molecular Weight
6.3.1 World Heparin Sodium Injection Production by Molecular Weight (2021-2032)
6.3.2 World Heparin Sodium Injection Production Value by Molecular Weight (2021-2032)
6.3.3 World Heparin Sodium Injection Average Price by Molecular Weight (2021-2032)
7 MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
7.1 World Heparin Sodium Injection Market Size Overview by Route of Administration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Route of Administration
7.2.1 Intravenous Injection (IV)
7.2.2 Subcutaneous Injection (SC)
7.3 Market Segment by Route of Administration
7.3.1 World Heparin Sodium Injection Production by Route of Administration (2021-2032)
7.3.2 World Heparin Sodium Injection Production Value by Route of Administration (2021-2032)
7.3.3 World Heparin Sodium Injection Average Price by Route of Administration (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Heparin Sodium Injection Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Treatment of Venous Thromboembolism
8.2.2 Complications of Pregnancy
8.2.3 Cardioversion of Atrial Fibrillation/Flutter
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Heparin Sodium Injection Production by Application (2021-2032)
8.3.2 World Heparin Sodium Injection Production Value by Application (2021-2032)
8.3.3 World Heparin Sodium Injection Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Pfizer
9.1.1 Pfizer Details
9.1.2 Pfizer Major Business
9.1.3 Pfizer Heparin Sodium Injection Product and Services
9.1.4 Pfizer Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Pfizer Recent Developments/Updates
9.1.6 Pfizer Competitive Strengths & Weaknesses
9.2 Teva Pharmaceutical Industries
9.2.1 Teva Pharmaceutical Industries Details
9.2.2 Teva Pharmaceutical Industries Major Business
9.2.3 Teva Pharmaceutical Industries Heparin Sodium Injection Product and Services
9.2.4 Teva Pharmaceutical Industries Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.2.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.3 Fresenius Kabi
9.3.1 Fresenius Kabi Details
9.3.2 Fresenius Kabi Major Business
9.3.3 Fresenius Kabi Heparin Sodium Injection Product and Services
9.3.4 Fresenius Kabi Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Fresenius Kabi Recent Developments/Updates
9.3.6 Fresenius Kabi Competitive Strengths & Weaknesses
9.4 Qilu Pharmaceutical
9.4.1 Qilu Pharmaceutical Details
9.4.2 Qilu Pharmaceutical Major Business
9.4.3 Qilu Pharmaceutical Heparin Sodium Injection Product and Services
9.4.4 Qilu Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Qilu Pharmaceutical Recent Developments/Updates
9.4.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
9.5 Cisen Pharmaceutical
9.5.1 Cisen Pharmaceutical Details
9.5.2 Cisen Pharmaceutical Major Business
9.5.3 Cisen Pharmaceutical Heparin Sodium Injection Product and Services
9.5.4 Cisen Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Cisen Pharmaceutical Recent Developments/Updates
9.5.6 Cisen Pharmaceutical Competitive Strengths & Weaknesses
9.6 Fosun Pharma
9.6.1 Fosun Pharma Details
9.6.2 Fosun Pharma Major Business
9.6.3 Fosun Pharma Heparin Sodium Injection Product and Services
9.6.4 Fosun Pharma Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Fosun Pharma Recent Developments/Updates
9.6.6 Fosun Pharma Competitive Strengths & Weaknesses
9.7 Changshan Biochemical Pharmaceutical
9.7.1 Changshan Biochemical Pharmaceutical Details
9.7.2 Changshan Biochemical Pharmaceutical Major Business
9.7.3 Changshan Biochemical Pharmaceutical Heparin Sodium Injection Product and Services
9.7.4 Changshan Biochemical Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Changshan Biochemical Pharmaceutical Recent Developments/Updates
9.7.6 Changshan Biochemical Pharmaceutical Competitive Strengths & Weaknesses
9.8 China Resources Double-Crane
9.8.1 China Resources Double-Crane Details
9.8.2 China Resources Double-Crane Major Business
9.8.3 China Resources Double-Crane Heparin Sodium Injection Product and Services
9.8.4 China Resources Double-Crane Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 China Resources Double-Crane Recent Developments/Updates
9.8.6 China Resources Double-Crane Competitive Strengths & Weaknesses
9.9 Shenzhen Hepalink Pharmaceutical
9.9.1 Shenzhen Hepalink Pharmaceutical Details
9.9.2 Shenzhen Hepalink Pharmaceutical Major Business
9.9.3 Shenzhen Hepalink Pharmaceutical Heparin Sodium Injection Product and Services
9.9.4 Shenzhen Hepalink Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
9.9.6 Shenzhen Hepalink Pharmaceutical Competitive Strengths & Weaknesses
9.10 Nanjing King-friend Biochemical Pharmaceutical
9.10.1 Nanjing King-friend Biochemical Pharmaceutical Details
9.10.2 Nanjing King-friend Biochemical Pharmaceutical Major Business
9.10.3 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium Injection Product and Services
9.10.4 Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
9.10.6 Nanjing King-friend Biochemical Pharmaceutical Competitive Strengths & Weaknesses
9.11 Chengdu Qianhong Bio-pharma
9.11.1 Chengdu Qianhong Bio-pharma Details
9.11.2 Chengdu Qianhong Bio-pharma Major Business
9.11.3 Chengdu Qianhong Bio-pharma Heparin Sodium Injection Product and Services
9.11.4 Chengdu Qianhong Bio-pharma Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.11.5 Chengdu Qianhong Bio-pharma Recent Developments/Updates
9.11.6 Chengdu Qianhong Bio-pharma Competitive Strengths & Weaknesses
9.12 Dongying Tiandong Pharmaceutical
9.12.1 Dongying Tiandong Pharmaceutical Details
9.12.2 Dongying Tiandong Pharmaceutical Major Business
9.12.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product and Services
9.12.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.12.5 Dongying Tiandong Pharmaceutical Recent Developments/Updates
9.12.6 Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
9.13 Jiangxi Haoran Bio-pharmaceutical
9.13.1 Jiangxi Haoran Bio-pharmaceutical Details
9.13.2 Jiangxi Haoran Bio-pharmaceutical Major Business
9.13.3 Jiangxi Haoran Bio-pharmaceutical Heparin Sodium Injection Product and Services
9.13.4 Jiangxi Haoran Bio-pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.13.5 Jiangxi Haoran Bio-pharmaceutical Recent Developments/Updates
9.13.6 Jiangxi Haoran Bio-pharmaceutical Competitive Strengths & Weaknesses
9.14 North China Pharmaceutical Group Huakun
9.14.1 North China Pharmaceutical Group Huakun Details
9.14.2 North China Pharmaceutical Group Huakun Major Business
9.14.3 North China Pharmaceutical Group Huakun Heparin Sodium Injection Product and Services
9.14.4 North China Pharmaceutical Group Huakun Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.14.5 North China Pharmaceutical Group Huakun Recent Developments/Updates
9.14.6 North China Pharmaceutical Group Huakun Competitive Strengths & Weaknesses
9.15 Chengdu Haitong Pharmaceutical
9.15.1 Chengdu Haitong Pharmaceutical Details
9.15.2 Chengdu Haitong Pharmaceutical Major Business
9.15.3 Chengdu Haitong Pharmaceutical Heparin Sodium Injection Product and Services
9.15.4 Chengdu Haitong Pharmaceutical Heparin Sodium Injection Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.15.5 Chengdu Haitong Pharmaceutical Recent Developments/Updates
9.15.6 Chengdu Haitong Pharmaceutical Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Heparin Sodium Injection Industry Chain
10.2 Heparin Sodium Injection Upstream Analysis
10.2.1 Heparin Sodium Injection Core Raw Materials
10.2.2 Main Manufacturers of Heparin Sodium Injection Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Heparin Sodium Injection Production Mode
10.6 Heparin Sodium Injection Procurement Model
10.7 Heparin Sodium Injection Industry Sales Model and Sales Channels
10.7.1 Heparin Sodium Injection Sales Model
10.7.2 Heparin Sodium Injection Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Heparin Sodium Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Heparin Sodium Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Heparin Sodium Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Heparin Sodium Injection Production Value Market Share by Region (2021-2026)
Table 5. World Heparin Sodium Injection Production Value Market Share by Region (2027-2032)
Table 6. World Heparin Sodium Injection Production by Region (2021-2026) & (K Units)
Table 7. World Heparin Sodium Injection Production by Region (2027-2032) & (K Units)
Table 8. World Heparin Sodium Injection Production Market Share by Region (2021-2026)
Table 9. World Heparin Sodium Injection Production Market Share by Region (2027-2032)
Table 10. World Heparin Sodium Injection Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Heparin Sodium Injection Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Heparin Sodium Injection Major Market Trends
Table 13. World Heparin Sodium Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Heparin Sodium Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Heparin Sodium Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Heparin Sodium Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Heparin Sodium Injection Producers in 2025
Table 18. World Heparin Sodium Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Heparin Sodium Injection Producers in 2025
Table 20. World Heparin Sodium Injection Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Heparin Sodium Injection Company Evaluation Quadrant
Table 22. World Heparin Sodium Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Heparin Sodium Injection Production Site of Key Manufacturer
Table 24. Heparin Sodium Injection Market: Company Product Type Footprint
Table 25. Heparin Sodium Injection Market: Company Product Application Footprint
Table 26. Heparin Sodium Injection Competitive Factors
Table 27. Heparin Sodium Injection New Entrant and Capacity Expansion Plans
Table 28. Heparin Sodium Injection Mergers & Acquisitions Activity
Table 29. United States VS China Heparin Sodium Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Heparin Sodium Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Heparin Sodium Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Heparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Heparin Sodium Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Heparin Sodium Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Heparin Sodium Injection Production Market Share (2021-2026)
Table 37. China Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Heparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Heparin Sodium Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Heparin Sodium Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Heparin Sodium Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Heparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Heparin Sodium Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Heparin Sodium Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Heparin Sodium Injection Production Market Share (2021-2026)
Table 47. World Heparin Sodium Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Heparin Sodium Injection Production by Type (2021-2026) & (K Units)
Table 49. World Heparin Sodium Injection Production by Type (2027-2032) & (K Units)
Table 50. World Heparin Sodium Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Heparin Sodium Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Heparin Sodium Injection Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Heparin Sodium Injection Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Heparin Sodium Injection Production Value by Molecular Weight, (USD Million), 2021 & 2025 & 2032
Table 55. World Heparin Sodium Injection Production by Molecular Weight (2021-2026) & (K Units)
Table 56. World Heparin Sodium Injection Production by Molecular Weight (2027-2032) & (K Units)
Table 57. World Heparin Sodium Injection Production Value by Molecular Weight (2021-2026) & (USD Million)
Table 58. World Heparin Sodium Injection Production Value by Molecular Weight (2027-2032) & (USD Million)
Table 59. World Heparin Sodium Injection Average Price by Molecular Weight (2021-2026) & (USD/Unit)
Table 60. World Heparin Sodium Injection Average Price by Molecular Weight (2027-2032) & (USD/Unit)
Table 61. World Heparin Sodium Injection Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 62. World Heparin Sodium Injection Production by Route of Administration (2021-2026) & (K Units)
Table 63. World Heparin Sodium Injection Production by Route of Administration (2027-2032) & (K Units)
Table 64. World Heparin Sodium Injection Production Value by Route of Administration (2021-2026) & (USD Million)
Table 65. World Heparin Sodium Injection Production Value by Route of Administration (2027-2032) & (USD Million)
Table 66. World Heparin Sodium Injection Average Price by Route of Administration (2021-2026) & (USD/Unit)
Table 67. World Heparin Sodium Injection Average Price by Route of Administration (2027-2032) & (USD/Unit)
Table 68. World Heparin Sodium Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Heparin Sodium Injection Production by Application (2021-2026) & (K Units)
Table 70. World Heparin Sodium Injection Production by Application (2027-2032) & (K Units)
Table 71. World Heparin Sodium Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Heparin Sodium Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Heparin Sodium Injection Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Heparin Sodium Injection Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Pfizer Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Heparin Sodium Injection Product and Services
Table 78. Pfizer Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Recent Developments/Updates
Table 80. Pfizer Competitive Strengths & Weaknesses
Table 81. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 82. Teva Pharmaceutical Industries Major Business
Table 83. Teva Pharmaceutical Industries Heparin Sodium Injection Product and Services
Table 84. Teva Pharmaceutical Industries Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Teva Pharmaceutical Industries Recent Developments/Updates
Table 86. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 87. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 88. Fresenius Kabi Major Business
Table 89. Fresenius Kabi Heparin Sodium Injection Product and Services
Table 90. Fresenius Kabi Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Fresenius Kabi Recent Developments/Updates
Table 92. Fresenius Kabi Competitive Strengths & Weaknesses
Table 93. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 94. Qilu Pharmaceutical Major Business
Table 95. Qilu Pharmaceutical Heparin Sodium Injection Product and Services
Table 96. Qilu Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Qilu Pharmaceutical Recent Developments/Updates
Table 98. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 99. Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. Cisen Pharmaceutical Major Business
Table 101. Cisen Pharmaceutical Heparin Sodium Injection Product and Services
Table 102. Cisen Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Cisen Pharmaceutical Recent Developments/Updates
Table 104. Cisen Pharmaceutical Competitive Strengths & Weaknesses
Table 105. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 106. Fosun Pharma Major Business
Table 107. Fosun Pharma Heparin Sodium Injection Product and Services
Table 108. Fosun Pharma Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Fosun Pharma Recent Developments/Updates
Table 110. Fosun Pharma Competitive Strengths & Weaknesses
Table 111. Changshan Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Changshan Biochemical Pharmaceutical Major Business
Table 113. Changshan Biochemical Pharmaceutical Heparin Sodium Injection Product and Services
Table 114. Changshan Biochemical Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 116. Changshan Biochemical Pharmaceutical Competitive Strengths & Weaknesses
Table 117. China Resources Double-Crane Basic Information, Manufacturing Base and Competitors
Table 118. China Resources Double-Crane Major Business
Table 119. China Resources Double-Crane Heparin Sodium Injection Product and Services
Table 120. China Resources Double-Crane Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. China Resources Double-Crane Recent Developments/Updates
Table 122. China Resources Double-Crane Competitive Strengths & Weaknesses
Table 123. Shenzhen Hepalink Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 124. Shenzhen Hepalink Pharmaceutical Major Business
Table 125. Shenzhen Hepalink Pharmaceutical Heparin Sodium Injection Product and Services
Table 126. Shenzhen Hepalink Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
Table 128. Shenzhen Hepalink Pharmaceutical Competitive Strengths & Weaknesses
Table 129. Nanjing King-friend Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Nanjing King-friend Biochemical Pharmaceutical Major Business
Table 131. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium Injection Product and Services
Table 132. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 134. Nanjing King-friend Biochemical Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Chengdu Qianhong Bio-pharma Basic Information, Manufacturing Base and Competitors
Table 136. Chengdu Qianhong Bio-pharma Major Business
Table 137. Chengdu Qianhong Bio-pharma Heparin Sodium Injection Product and Services
Table 138. Chengdu Qianhong Bio-pharma Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Chengdu Qianhong Bio-pharma Recent Developments/Updates
Table 140. Chengdu Qianhong Bio-pharma Competitive Strengths & Weaknesses
Table 141. Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 142. Dongying Tiandong Pharmaceutical Major Business
Table 143. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product and Services
Table 144. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 146. Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
Table 147. Jiangxi Haoran Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 148. Jiangxi Haoran Bio-pharmaceutical Major Business
Table 149. Jiangxi Haoran Bio-pharmaceutical Heparin Sodium Injection Product and Services
Table 150. Jiangxi Haoran Bio-pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Jiangxi Haoran Bio-pharmaceutical Recent Developments/Updates
Table 152. Jiangxi Haoran Bio-pharmaceutical Competitive Strengths & Weaknesses
Table 153. North China Pharmaceutical Group Huakun Basic Information, Manufacturing Base and Competitors
Table 154. North China Pharmaceutical Group Huakun Major Business
Table 155. North China Pharmaceutical Group Huakun Heparin Sodium Injection Product and Services
Table 156. North China Pharmaceutical Group Huakun Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. North China Pharmaceutical Group Huakun Recent Developments/Updates
Table 158. North China Pharmaceutical Group Huakun Competitive Strengths & Weaknesses
Table 159. Chengdu Haitong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 160. Chengdu Haitong Pharmaceutical Major Business
Table 161. Chengdu Haitong Pharmaceutical Heparin Sodium Injection Product and Services
Table 162. Chengdu Haitong Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Chengdu Haitong Pharmaceutical Recent Developments/Updates
Table 164. Chengdu Haitong Pharmaceutical Competitive Strengths & Weaknesses
Table 165. Global Key Players of Heparin Sodium Injection Upstream (Raw Materials)
Table 166. Global Heparin Sodium Injection Typical Customers
Table 167. Heparin Sodium Injection Typical Distributors
Table 1. World Heparin Sodium Injection Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Heparin Sodium Injection Production Value by Region (2021-2026) & (USD Million)
Table 3. World Heparin Sodium Injection Production Value by Region (2027-2032) & (USD Million)
Table 4. World Heparin Sodium Injection Production Value Market Share by Region (2021-2026)
Table 5. World Heparin Sodium Injection Production Value Market Share by Region (2027-2032)
Table 6. World Heparin Sodium Injection Production by Region (2021-2026) & (K Units)
Table 7. World Heparin Sodium Injection Production by Region (2027-2032) & (K Units)
Table 8. World Heparin Sodium Injection Production Market Share by Region (2021-2026)
Table 9. World Heparin Sodium Injection Production Market Share by Region (2027-2032)
Table 10. World Heparin Sodium Injection Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Heparin Sodium Injection Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Heparin Sodium Injection Major Market Trends
Table 13. World Heparin Sodium Injection Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Heparin Sodium Injection Consumption by Region (2021-2026) & (K Units)
Table 15. World Heparin Sodium Injection Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Heparin Sodium Injection Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Heparin Sodium Injection Producers in 2025
Table 18. World Heparin Sodium Injection Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Heparin Sodium Injection Producers in 2025
Table 20. World Heparin Sodium Injection Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Heparin Sodium Injection Company Evaluation Quadrant
Table 22. World Heparin Sodium Injection Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Heparin Sodium Injection Production Site of Key Manufacturer
Table 24. Heparin Sodium Injection Market: Company Product Type Footprint
Table 25. Heparin Sodium Injection Market: Company Product Application Footprint
Table 26. Heparin Sodium Injection Competitive Factors
Table 27. Heparin Sodium Injection New Entrant and Capacity Expansion Plans
Table 28. Heparin Sodium Injection Mergers & Acquisitions Activity
Table 29. United States VS China Heparin Sodium Injection Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Heparin Sodium Injection Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Heparin Sodium Injection Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Heparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Heparin Sodium Injection Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Heparin Sodium Injection Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Heparin Sodium Injection Production Market Share (2021-2026)
Table 37. China Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Heparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Heparin Sodium Injection Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Heparin Sodium Injection Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Heparin Sodium Injection Production Market Share (2021-2026)
Table 42. Rest of World Based Heparin Sodium Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Heparin Sodium Injection Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Heparin Sodium Injection Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Heparin Sodium Injection Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Heparin Sodium Injection Production Market Share (2021-2026)
Table 47. World Heparin Sodium Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Heparin Sodium Injection Production by Type (2021-2026) & (K Units)
Table 49. World Heparin Sodium Injection Production by Type (2027-2032) & (K Units)
Table 50. World Heparin Sodium Injection Production Value by Type (2021-2026) & (USD Million)
Table 51. World Heparin Sodium Injection Production Value by Type (2027-2032) & (USD Million)
Table 52. World Heparin Sodium Injection Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Heparin Sodium Injection Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Heparin Sodium Injection Production Value by Molecular Weight, (USD Million), 2021 & 2025 & 2032
Table 55. World Heparin Sodium Injection Production by Molecular Weight (2021-2026) & (K Units)
Table 56. World Heparin Sodium Injection Production by Molecular Weight (2027-2032) & (K Units)
Table 57. World Heparin Sodium Injection Production Value by Molecular Weight (2021-2026) & (USD Million)
Table 58. World Heparin Sodium Injection Production Value by Molecular Weight (2027-2032) & (USD Million)
Table 59. World Heparin Sodium Injection Average Price by Molecular Weight (2021-2026) & (USD/Unit)
Table 60. World Heparin Sodium Injection Average Price by Molecular Weight (2027-2032) & (USD/Unit)
Table 61. World Heparin Sodium Injection Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 62. World Heparin Sodium Injection Production by Route of Administration (2021-2026) & (K Units)
Table 63. World Heparin Sodium Injection Production by Route of Administration (2027-2032) & (K Units)
Table 64. World Heparin Sodium Injection Production Value by Route of Administration (2021-2026) & (USD Million)
Table 65. World Heparin Sodium Injection Production Value by Route of Administration (2027-2032) & (USD Million)
Table 66. World Heparin Sodium Injection Average Price by Route of Administration (2021-2026) & (USD/Unit)
Table 67. World Heparin Sodium Injection Average Price by Route of Administration (2027-2032) & (USD/Unit)
Table 68. World Heparin Sodium Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Heparin Sodium Injection Production by Application (2021-2026) & (K Units)
Table 70. World Heparin Sodium Injection Production by Application (2027-2032) & (K Units)
Table 71. World Heparin Sodium Injection Production Value by Application (2021-2026) & (USD Million)
Table 72. World Heparin Sodium Injection Production Value by Application (2027-2032) & (USD Million)
Table 73. World Heparin Sodium Injection Average Price by Application (2021-2026) & (USD/Unit)
Table 74. World Heparin Sodium Injection Average Price by Application (2027-2032) & (USD/Unit)
Table 75. Pfizer Basic Information, Manufacturing Base and Competitors
Table 76. Pfizer Major Business
Table 77. Pfizer Heparin Sodium Injection Product and Services
Table 78. Pfizer Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Pfizer Recent Developments/Updates
Table 80. Pfizer Competitive Strengths & Weaknesses
Table 81. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 82. Teva Pharmaceutical Industries Major Business
Table 83. Teva Pharmaceutical Industries Heparin Sodium Injection Product and Services
Table 84. Teva Pharmaceutical Industries Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Teva Pharmaceutical Industries Recent Developments/Updates
Table 86. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 87. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 88. Fresenius Kabi Major Business
Table 89. Fresenius Kabi Heparin Sodium Injection Product and Services
Table 90. Fresenius Kabi Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Fresenius Kabi Recent Developments/Updates
Table 92. Fresenius Kabi Competitive Strengths & Weaknesses
Table 93. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 94. Qilu Pharmaceutical Major Business
Table 95. Qilu Pharmaceutical Heparin Sodium Injection Product and Services
Table 96. Qilu Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Qilu Pharmaceutical Recent Developments/Updates
Table 98. Qilu Pharmaceutical Competitive Strengths & Weaknesses
Table 99. Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 100. Cisen Pharmaceutical Major Business
Table 101. Cisen Pharmaceutical Heparin Sodium Injection Product and Services
Table 102. Cisen Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Cisen Pharmaceutical Recent Developments/Updates
Table 104. Cisen Pharmaceutical Competitive Strengths & Weaknesses
Table 105. Fosun Pharma Basic Information, Manufacturing Base and Competitors
Table 106. Fosun Pharma Major Business
Table 107. Fosun Pharma Heparin Sodium Injection Product and Services
Table 108. Fosun Pharma Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Fosun Pharma Recent Developments/Updates
Table 110. Fosun Pharma Competitive Strengths & Weaknesses
Table 111. Changshan Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 112. Changshan Biochemical Pharmaceutical Major Business
Table 113. Changshan Biochemical Pharmaceutical Heparin Sodium Injection Product and Services
Table 114. Changshan Biochemical Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Changshan Biochemical Pharmaceutical Recent Developments/Updates
Table 116. Changshan Biochemical Pharmaceutical Competitive Strengths & Weaknesses
Table 117. China Resources Double-Crane Basic Information, Manufacturing Base and Competitors
Table 118. China Resources Double-Crane Major Business
Table 119. China Resources Double-Crane Heparin Sodium Injection Product and Services
Table 120. China Resources Double-Crane Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. China Resources Double-Crane Recent Developments/Updates
Table 122. China Resources Double-Crane Competitive Strengths & Weaknesses
Table 123. Shenzhen Hepalink Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 124. Shenzhen Hepalink Pharmaceutical Major Business
Table 125. Shenzhen Hepalink Pharmaceutical Heparin Sodium Injection Product and Services
Table 126. Shenzhen Hepalink Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Shenzhen Hepalink Pharmaceutical Recent Developments/Updates
Table 128. Shenzhen Hepalink Pharmaceutical Competitive Strengths & Weaknesses
Table 129. Nanjing King-friend Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 130. Nanjing King-friend Biochemical Pharmaceutical Major Business
Table 131. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium Injection Product and Services
Table 132. Nanjing King-friend Biochemical Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. Nanjing King-friend Biochemical Pharmaceutical Recent Developments/Updates
Table 134. Nanjing King-friend Biochemical Pharmaceutical Competitive Strengths & Weaknesses
Table 135. Chengdu Qianhong Bio-pharma Basic Information, Manufacturing Base and Competitors
Table 136. Chengdu Qianhong Bio-pharma Major Business
Table 137. Chengdu Qianhong Bio-pharma Heparin Sodium Injection Product and Services
Table 138. Chengdu Qianhong Bio-pharma Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. Chengdu Qianhong Bio-pharma Recent Developments/Updates
Table 140. Chengdu Qianhong Bio-pharma Competitive Strengths & Weaknesses
Table 141. Dongying Tiandong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 142. Dongying Tiandong Pharmaceutical Major Business
Table 143. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product and Services
Table 144. Dongying Tiandong Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Dongying Tiandong Pharmaceutical Recent Developments/Updates
Table 146. Dongying Tiandong Pharmaceutical Competitive Strengths & Weaknesses
Table 147. Jiangxi Haoran Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 148. Jiangxi Haoran Bio-pharmaceutical Major Business
Table 149. Jiangxi Haoran Bio-pharmaceutical Heparin Sodium Injection Product and Services
Table 150. Jiangxi Haoran Bio-pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Jiangxi Haoran Bio-pharmaceutical Recent Developments/Updates
Table 152. Jiangxi Haoran Bio-pharmaceutical Competitive Strengths & Weaknesses
Table 153. North China Pharmaceutical Group Huakun Basic Information, Manufacturing Base and Competitors
Table 154. North China Pharmaceutical Group Huakun Major Business
Table 155. North China Pharmaceutical Group Huakun Heparin Sodium Injection Product and Services
Table 156. North China Pharmaceutical Group Huakun Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. North China Pharmaceutical Group Huakun Recent Developments/Updates
Table 158. North China Pharmaceutical Group Huakun Competitive Strengths & Weaknesses
Table 159. Chengdu Haitong Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 160. Chengdu Haitong Pharmaceutical Major Business
Table 161. Chengdu Haitong Pharmaceutical Heparin Sodium Injection Product and Services
Table 162. Chengdu Haitong Pharmaceutical Heparin Sodium Injection Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Chengdu Haitong Pharmaceutical Recent Developments/Updates
Table 164. Chengdu Haitong Pharmaceutical Competitive Strengths & Weaknesses
Table 165. Global Key Players of Heparin Sodium Injection Upstream (Raw Materials)
Table 166. Global Heparin Sodium Injection Typical Customers
Table 167. Heparin Sodium Injection Typical Distributors
LIST OF FIGURES
Figure 1. Heparin Sodium Injection Picture
Figure 2. World Heparin Sodium Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Heparin Sodium Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 5. World Heparin Sodium Injection Average Price (2021-2032) & (USD/Unit)
Figure 6. World Heparin Sodium Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Heparin Sodium Injection Production Market Share by Region (2021-2032)
Figure 8. North America Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 9. Europe Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 10. China Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 11. Japan Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 12. India Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 13. Heparin Sodium Injection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 16. World Heparin Sodium Injection Consumption Market Share by Region (2021-2032)
Figure 17. United States Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 18. China Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 19. Europe Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 20. Japan Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 21. South Korea Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 22. ASEAN Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 23. India Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 24. Producer Shipments of Heparin Sodium Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Heparin Sodium Injection Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Heparin Sodium Injection Markets in 2025
Figure 27. United States VS China: Heparin Sodium Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Heparin Sodium Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Heparin Sodium Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Heparin Sodium Injection Production Market Share 2025
Figure 31. China Based Manufacturers Heparin Sodium Injection Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Heparin Sodium Injection Production Market Share 2025
Figure 33. World Heparin Sodium Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Heparin Sodium Injection Production Value Market Share by Type in 2025
Figure 35. 1, 000 USP Units / mL
Figure 36. 5, 000 USP Units / mL
Figure 37. 10, 000 USP Units / mL
Figure 38. World Heparin Sodium Injection Production Market Share by Type (2021-2032)
Figure 39. World Heparin Sodium Injection Production Value Market Share by Type (2021-2032)
Figure 40. World Heparin Sodium Injection Average Price by Type (2021-2032) & (USD/Unit)
Figure 41. World Heparin Sodium Injection Production Value by Molecular Weight, (USD Million), 2021 & 2025 & 2032
Figure 42. World Heparin Sodium Injection Production Value Market Share by Molecular Weight in 2025
Figure 43. Unfractionated Heparin (UFH)
Figure 44. Low Molecular Weight Heparin (LMWH)
Figure 45. World Heparin Sodium Injection Production Market Share by Molecular Weight (2021-2032)
Figure 46. World Heparin Sodium Injection Production Value Market Share by Molecular Weight (2021-2032)
Figure 47. World Heparin Sodium Injection Average Price by Molecular Weight (2021-2032) & (USD/Unit)
Figure 48. World Heparin Sodium Injection Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 49. World Heparin Sodium Injection Production Value Market Share by Route of Administration in 2025
Figure 50. Intravenous Injection (IV)
Figure 51. Subcutaneous Injection (SC)
Figure 52. World Heparin Sodium Injection Production Market Share by Route of Administration (2021-2032)
Figure 53. World Heparin Sodium Injection Production Value Market Share by Route of Administration (2021-2032)
Figure 54. World Heparin Sodium Injection Average Price by Route of Administration (2021-2032) & (USD/Unit)
Figure 55. World Heparin Sodium Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Heparin Sodium Injection Production Value Market Share by Application in 2025
Figure 57. Treatment of Venous Thromboembolism
Figure 58. Complications of Pregnancy
Figure 59. Cardioversion of Atrial Fibrillation/Flutter
Figure 60. Other
Figure 61. World Heparin Sodium Injection Production Market Share by Application (2021-2032)
Figure 62. World Heparin Sodium Injection Production Value Market Share by Application (2021-2032)
Figure 63. World Heparin Sodium Injection Average Price by Application (2021-2032) & (USD/Unit)
Figure 64. Heparin Sodium Injection Industry Chain
Figure 65. Heparin Sodium Injection Procurement Model
Figure 66. Heparin Sodium Injection Sales Model
Figure 67. Heparin Sodium Injection Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Heparin Sodium Injection Picture
Figure 2. World Heparin Sodium Injection Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Heparin Sodium Injection Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 5. World Heparin Sodium Injection Average Price (2021-2032) & (USD/Unit)
Figure 6. World Heparin Sodium Injection Production Value Market Share by Region (2021-2032)
Figure 7. World Heparin Sodium Injection Production Market Share by Region (2021-2032)
Figure 8. North America Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 9. Europe Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 10. China Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 11. Japan Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 12. India Heparin Sodium Injection Production (2021-2032) & (K Units)
Figure 13. Heparin Sodium Injection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 16. World Heparin Sodium Injection Consumption Market Share by Region (2021-2032)
Figure 17. United States Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 18. China Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 19. Europe Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 20. Japan Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 21. South Korea Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 22. ASEAN Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 23. India Heparin Sodium Injection Consumption (2021-2032) & (K Units)
Figure 24. Producer Shipments of Heparin Sodium Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Heparin Sodium Injection Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Heparin Sodium Injection Markets in 2025
Figure 27. United States VS China: Heparin Sodium Injection Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Heparin Sodium Injection Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Heparin Sodium Injection Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Heparin Sodium Injection Production Market Share 2025
Figure 31. China Based Manufacturers Heparin Sodium Injection Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Heparin Sodium Injection Production Market Share 2025
Figure 33. World Heparin Sodium Injection Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Heparin Sodium Injection Production Value Market Share by Type in 2025
Figure 35. 1, 000 USP Units / mL
Figure 36. 5, 000 USP Units / mL
Figure 37. 10, 000 USP Units / mL
Figure 38. World Heparin Sodium Injection Production Market Share by Type (2021-2032)
Figure 39. World Heparin Sodium Injection Production Value Market Share by Type (2021-2032)
Figure 40. World Heparin Sodium Injection Average Price by Type (2021-2032) & (USD/Unit)
Figure 41. World Heparin Sodium Injection Production Value by Molecular Weight, (USD Million), 2021 & 2025 & 2032
Figure 42. World Heparin Sodium Injection Production Value Market Share by Molecular Weight in 2025
Figure 43. Unfractionated Heparin (UFH)
Figure 44. Low Molecular Weight Heparin (LMWH)
Figure 45. World Heparin Sodium Injection Production Market Share by Molecular Weight (2021-2032)
Figure 46. World Heparin Sodium Injection Production Value Market Share by Molecular Weight (2021-2032)
Figure 47. World Heparin Sodium Injection Average Price by Molecular Weight (2021-2032) & (USD/Unit)
Figure 48. World Heparin Sodium Injection Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 49. World Heparin Sodium Injection Production Value Market Share by Route of Administration in 2025
Figure 50. Intravenous Injection (IV)
Figure 51. Subcutaneous Injection (SC)
Figure 52. World Heparin Sodium Injection Production Market Share by Route of Administration (2021-2032)
Figure 53. World Heparin Sodium Injection Production Value Market Share by Route of Administration (2021-2032)
Figure 54. World Heparin Sodium Injection Average Price by Route of Administration (2021-2032) & (USD/Unit)
Figure 55. World Heparin Sodium Injection Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 56. World Heparin Sodium Injection Production Value Market Share by Application in 2025
Figure 57. Treatment of Venous Thromboembolism
Figure 58. Complications of Pregnancy
Figure 59. Cardioversion of Atrial Fibrillation/Flutter
Figure 60. Other
Figure 61. World Heparin Sodium Injection Production Market Share by Application (2021-2032)
Figure 62. World Heparin Sodium Injection Production Value Market Share by Application (2021-2032)
Figure 63. World Heparin Sodium Injection Average Price by Application (2021-2032) & (USD/Unit)
Figure 64. Heparin Sodium Injection Industry Chain
Figure 65. Heparin Sodium Injection Procurement Model
Figure 66. Heparin Sodium Injection Sales Model
Figure 67. Heparin Sodium Injection Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
